| CEO Name | Thomas Schinecker |
| Nationality | Germany |
| Net Worth Estimation | $30 million |
Thomas Schinecker's estimated net worth of around $30 million is primarily attributed to his executive compensation, stock grants, and performance-based bonuses at Roche Holding AG, as well as his long-standing career within the pharmaceutical industry. This valuation also considers his holdings in Roche shares and related company benefits.
Thomas Schinecker's estimated net worth of $30,000,000 places him at 25% of the maximum and 33.3% above the minimum CEO net worth in the healthcare category provided. This suggests his wealth is well within the upper third of the specified range for CEOs in this sector.
Business Category: Healthcare
Minimum Net Worth (estimation): 10000000 USD
Maximum Net Worth (estimation): 90000000 USD
Thomas Schinecker Performance in Roche Holding AG
Thomas Schinecker, CEO of Roche Holding AG, demonstrates strategic leadership by driving innovation and digital transformation in pharmaceutical development. His decisive approach emphasizes patient-centric solutions and operational efficiency, boosting the company's market presence and R&D productivity. Under Schinecker's tenure, Roche has strengthened its competitive position through enhanced pipeline development and global expansion, significantly increasing shareholder value.
Latest News
Roche Holding AG Reports Strong 2025 Growth and Strategic Acquisitions
Roche achieved 7% sales growth in the first nine months of 2025, with CEO Thomas Schinecker confirming no job cuts and a healthy business outlook, despite market challenges. The company also advanced its pipeline through major deals, including the acquisition of 89bio and a $1B+ bispecific antibody partnership.
Source: http://www.roche.com/media/releases/med-cor-2025-10-23